每周股票复盘：方盛制药（603998）推进新激励计划与市值管理

Group 1 - The stock price of Fangsheng Pharmaceutical (603998) closed at 10.53 yuan on May 30, 2025, up 6.26% from 9.91 yuan the previous week, with a market capitalization of 4.624 billion yuan [1] - The stock reached a high of 10.6 yuan and a low of 9.61 yuan during the week [1] - Fangsheng Pharmaceutical ranks 41st out of 68 in the traditional Chinese medicine sector and 3085th out of 5146 in the A-share market [1] Group 2 - The company is considering a new incentive plan, which will be based on future strategies and market conditions [2][4] - Market value management has been incorporated into the performance evaluation of some senior management, emphasizing communication with investors and a stable dividend policy [2][4] - The innovative traditional Chinese medicine product, Yao Xue Qu Feng Zhi Tong Granules, has submitted a listing application to the National Medical Products Administration and is currently under review [3][4]